In these rapidly changing and sometimes tumultuous economic times, it has become even more important for biotech companies to seek efficiencies in their biologics development and manufacturing.  Opportunities to leverage technological innovation and synergistic CDMO partnership offer a competitive edge and the ability to weather various global pressures, whether they be tariffs, supply chain disruption, healthcare accessibility, environmental responsibility, or rising production costs.

This half-day symposium will address such real-world topics as

The event will be divided into four sessions including a mix of didactic and interactive panel discussions.  Integrating the experience and technology of an innovative, disruptive CDMO with the diverse perspectives of consultants and biotech manufacturers, the symposium promises to stimulate interesting dialogue that can transform the way the biologics industry thinks about cost efficiency and integration of high-yield processes for biologics manufacturing.